Christopher Rogers, M.Sc. is senior manager, Regulatory Affairs, CMC at PharmaLex UK. He has 20 years of experience in biologics development and manufacturing, with a focus on routine and advanced analytics from characterization through analytical development and quality control for CMC. Chris is now supporting regulatory CMC in projects including new product development, EU and U.S. submissions and regulatory interactions, life cycle management, and project management in monoclonal antibodies, biosimilars and ATMP products.

Prior to becoming a regulatory consultant, Chris worked in the pharmaceutical industry for more than 15 years, with experience including QC release, discovery and development phases on a range of products. Chris also worked for four years as a mass spectrometrist supporting biopharmaceutical characterization with advanced mass spectrometry.

Chris holds a BSc in Biology (University of Hull) and a M.Sc. in Analytical Bioscience and Drug Design (University of Salford) and is a keen cyclist.